Wolverine Asset Management LLC Innoviva, Inc. Put Options Transaction History

Wolverine Asset Management LLC

10 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2020 Aug 13, 2020	SELL	$11.49 - $15.26 $271,164 - $360,136	-23,600 Closed	0 $0
Q1 2020 May 13, 2020	SELL	$8.11 - $15.23 $278,173 - $522,389	-34,300 Reduced 59.24%	23,600 $277,000
Q4 2019 Feb 14, 2020	BUY	$10.28 - $14.38 $491,383 - $687,364	47,800 Added 473.27%	57,900 $819,000
Q3 2019 Nov 14, 2019	SELL	$10.05 - $14.55 $917,565 - $1.33 Million	-91,300 Reduced 90.04%	10,100 $106,000
Q2 2019 Aug 14, 2019	BUY	$13.1 - $14.95 $1.33 Million - $1.52 Million	101,400 New	101,400 $1.48 Million
Q1 2019 May 15, 2019	SELL	$13.69 - $20.06 $1.06 Million - $1.55 Million	-77,200 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$13.96 - $18.26 $103,304 - $135,124	7,400 Added 10.6%	77,200 $1.35 Million
Q1 2018 May 15, 2018	SELL	$13.8 - $16.99 $1.64 Million - $2.02 Million	-118,700 Reduced 62.97%	69,800 $1.16 Million
Q4 2017 Feb 14, 2018	BUY	$11.73 - $14.75 $1.39 Million - $1.75 Million	118,600 Added 169.67%	188,500 $2.67 Million
Q3 2017 Nov 14, 2017	BUY	$12.06 - $14.12 $842,994 - $986,988	69,900	69,900 $986,000

229

79.2M

37.6K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.32B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Asset Management LLC with notifications on news.